Prophylaxis With Valganciclovir in Anti–Melanoma Differentiation Associated 5 Gene Antibody Dermatomyositis: A Cohort Study in China
Prophylaxis with valganciclovir can reduce the incidence of CMV infection during MDA5 + DM treatment. It exerts a potential auxiliary effect on MDA5 + DM treatment.
Authors
- Xia Liu (ORCID: https://orcid.org/0000-0002-0039-4754)
- Lu Zhang (ORCID: https://orcid.org/0000-0001-8358-6112)
- Ling Zhang (ORCID: https://orcid.org/0000-0001-5247-3350)
- Xiaoxing Wang (ORCID: https://orcid.org/0000-0003-2930-5265)
- Li Shanshan (ORCID: https://orcid.org/0000-0001-8525-7224)
- Duan Jianghui
Institutions
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1097/rhu.0000000000002274
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 1.35